European Medicines Agency - Regulatory - Regulation of medicines

1 - Research experience and ability



  Description

Name

ITCC - Innovative Therapies for Children with Cancer

Number of completed trials 12
Number of ongoing trials 21
Total number of participants actually recruited each year 100
Proportion of eligible participants actually recruited each year 300
Describe way of screening and participant recruitment Paediatrics patients with recurrent or refractory malignancies are proposed to be included in an early clinical trial in the absence of efficient treatment strategies. Recruitment is limited due to the insufficient number of accessible trials.
Total number of collaborating centres 43
Academic investigator initiated studies
Number of ongoing and completed clinical trials. Absolute number 11
Number of ongoing and completed clinical trials. Proportion of all studies 11/32 = 34%
Number of paediatric specialties covered by paediatric trials] 6
Number of paediatric conditions covered by paediatric trials] 6
Number of other ongoing research studies programs] 4
Proportion of academic initiated studies 34%
Proportion of budget 60%
Number of registered study participants.
All studies
411
Number of ongoing and completed trials 22
Number of paediatric specialties covered by paediatric trials 6
Number of paediatric conditions covered by paediatric trialss 6
Number of registered study participants all studies 629